Finance Home - My Yahoo - Yahoo! - Help

Wednesday, December 30, 2009, 5:42PM ET - U.S. Markets Closed. Dow  0.03% Nasdaq  0.13%

China Aoxing Pharmaceutical Co., Inc. (CAXG.OB)

At 3:34PM ET: 0.94   0.04 (4.08%)

MORE ON CAXG.OB

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Mon, Dec 21, 2009 • China Aoxing Pharmaceutical Company Receives GMP Re-Certification of Four Drug Dosage Forms at New Manufacture Facility Marketwire (Mon, Dec 21) Mon, Nov 30, 2009 • CHINA AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Other Events EDGAR Online (Mon, Nov 30) Sat, Nov 28, 2009 • CHINA AOXING PHARMACEUTICAL COMPANY, INC. Financials EDGAR Online Financials (Sat, Nov 28) Tue, Nov 24, 2009 • China Aoxing Pharmaceutical Company Reports First Quarter 2010 Financial and Operational Results Marketwire (Tue, Nov 24) Mon, Nov 23, 2009 • CHINA AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Mon, Nov 23) Thu, Nov 12, 2009 • American Oriental Bioengineering: Questionable Acquisitions at Seeking Alpha (Thu, Nov 12) Tue, Nov 10, 2009 • China Aoxing Pharmaceutical Company to Present at Brean Murray, Carret & Co. 2009 China Growth Conference Marketwire (Tue, Nov 10) Mon, Oct 19, 2009 • China Aoxing Pharmaceutical Company to Present at 2009 China Growth Conference of Adam Friedman Associates on October 28, 2009 PR Newswire (Mon, Oct 19) Wed, Oct 14, 2009 • China Aoxing Pharmaceutical Company Reports Fiscal Year 2009 Financial Results Marketwire (Wed, Oct 14) • CHINA AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-K, Annual Report EDGAR Online (Wed, Oct 14) Tue, Oct 6, 2009 • China Aoxing Pharmaceutical Company to Present at 2009 Roth China Conference PR Newswire (Tue, Oct 6) Thu, Sep 24, 2009 • CHINA AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 10-K/A, Annual Report EDGAR Online (Thu, Sep 24) • China Aoxing Pharmaceutical Company Honorably Awarded Center of Excellence in Enterprise Technology by Consortium of China Government Offices Marketwire (Thu, Sep 24) Thu, Sep 17, 2009 • China Aoxing Pharmaceutical Company Receives SFDA Approval for Clinical Trial of Abuse Resistant Opioid Drug Marketwire (Thu, Sep 17) Thu, Sep 3, 2009 • China Aoxing Pharmaceutical Company Announces Submission of NDA of Its Leading Narcotic Drug for the Treatment of Acute Moderate to Severe Cough Marketwire (Thu, Sep 3) Wed, Aug 12, 2009 • CHINA AOXING PHARMACEUTICAL COMPANY, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial State EDGAR Online (Wed, Aug 12) Thu, Aug 6, 2009 • / CORRECTION - China Aoxing Pharmaceutical Company Announces Completion of $5 Million Private Placement of Common Stock Marketwire (Thu, Aug 6) • China Aoxing Pharmaceutical Company Announces Completion of $5 Million Private Placement of Common Stock Marketwire (Thu, Aug 6) Thu, Jul 23, 2009 • China Aoxing Pharmaceutical Company Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products Marketwire (Thu, Jul 23) Thu, Jun 18, 2009 • China Aoxing Pharmaceutical Company Announces Completion of Registration Trial of Its Leading Narcotic Drug for the Treatment of Acute Moderate to Severe Cough Marketwire (Thu, Jun 18) Older Headlines - Download Recent Headlines View headlines from: Thu, Jun 18, 2009Thu, Jun 11, 2009Thu, Jun 4, 2009Thu, May 28, 2009Thu, May 21, 2009Thu, May 14, 2009Thu, May 7, 2009Thu, Apr 30, 2009Thu, Apr 23, 2009Thu, Apr 16, 2009 Add CAXG.OB News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage